期刊文献+

胸中段食管癌左右胸两种手术径路的临床研究

Clinical study of two kinds of surgical approaches for the treatment of middle thoracic esophageal cancer
暂未订购
导出
摘要 目的:比较左、右胸手术径路治疗胸中段食管癌患者的临床效果。方法:选取68例胸中段食管癌患者,随机分为研究组(34例)和对照组(34例),研究组行左胸径路手术治疗,对照组行右胸径路手术治疗,比较两组患者的治疗效果。结果:与研究组比较,对照组的手术时间、术中出血量、淋巴结清扫个数明显增多,差异显著,有统计学意义(P <0. 01),对照组的肿瘤切除率97. 06%,明显高于研究组的肿瘤切除率82. 35%,差异有统计学意义(P <0. 05);对照组无切缘癌残留,研究组切缘癌残留率11. 76%,差异具有统计学意义(P <0. 05)。对照组的并发症发生率为32. 35%,明显高于研究组并发症发生率11. 76%,差异具有统计学意义(P <0. 05)。结论:右胸径路治疗胸中段食管癌患者手术耗时长,术中出血量多,并发症较多,但淋巴结清扫更为彻底,肿瘤切除率高,治疗效果显著,值得临床推广应用。 Objective To compare the clinical effects of left and right thoracic surgical approaches in the treatment of patients with middle thoracic esophageal cancer. Method 68 cases of middle thoracic esophageal cancer were randomly divided into study group (34 cases) and control group (34 cases). The study group was treated with left thoracic approach surgery, and the control group was treated with right thoracic approach surgery, and the treatment effect of the two groups was com- pared. Results Compared with the study group,the operation time,intraoperative blood loss, and the number of lymph node dis- section of the control group increased significantly,with significant differences (P 〉 0. 01 ). The tumor resection rate of the control group was 97. 06% ,which was significantly higher than that of the study group (82. 35% ) (P 〈 0. 05) ;There was no residual margin cancer in the control group, and the residual rate of margin cancer in the study group was 11.76 %, the difference was sta- tistically significant (P 〈 0. 05 ). The complication rate of the control group was 32. 35% ,which was significantly higher than that of the study group ( 11.76 % ), the difference was statistically significant ( P 〈 0. 05 ). Conclusion Right thoracic approach for the treatment of patients with middle thoracic esophagus cancer has long time, more bleeding and more complications, but the lymph node dissection is more thorough, the tumor resection rate is high, the treatment effect is remarkable, and it is worthy of clinical application.
作者 廖裕彬 冯家宁 陆剑豪 LIAO Yu-bin;FENG Jia-ning;LU Jian-hao(Department of Cardiothoracic Surgery,Guangdong Tongjiang Hospital,Tongjiang 528300,China)
出处 《吉林医学》 CAS 2018年第10期1826-1828,共3页 Jilin Medical Journal
基金 佛山市卫生和计生局医学科研课题[项目名称:20170363]
关键词 右胸径路 左胸径路 胸中段食管癌 临床效果 Right thoracic approach Left thoracic approach Middle thoracic esophageal cancer Clinical effect
  • 相关文献

参考文献9

二级参考文献63

  • 1邹小农,陈万青,张思维,李连弟,鲁凤珠,陈永红,赵平.中国部分市县1998~2002年食管癌发病与死亡[J].中国肿瘤,2007,16(3):142-146. 被引量:53
  • 2孙衍庆 主编.现代胸心外科学[M].北京:人民军医出版社,2000.516-517.
  • 3郭昭扬,俞力超,徐新华,等.胸段食管癌颈部及上纵隔淋巴结转移[J].中华胸心血管外科杂志,2011,14(10):245-244.
  • 4Hong Hu, Ting Ye, Yawei Zhang, et al. Modifications in retrostemal reconstruction after oesophago-gastrectomy may reduce the incidence of anastomotic leakage[J]. Euro- pean Journal of Cardio-Thoracic Surgery, 2012 (42) : 359- 363.
  • 5黄国俊.半个世纪以来我国食管癌外科治疗的基本经验[J].中华肿瘤杂志,2007,29(10):795-797.
  • 6Ferlay J,Shin H R,Bray F,et al.Estimates of worldwide burden of cancer in 2008:GLOBOCAN 2008[J].International Journal of Cancer,2010,127(12):2893~2917.
  • 7Rolff H C,Simonsen L R,Rosenberg J.Clinical findings confirm national guidelines regarding primary gastroscopy for upper gastrointestinal symptoms[J].Cancer,2011,1(2):1~5.
  • 8Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008 .. GLOBOCAN 2008 E J ]. Int J Cancer, 2010, 127(12): 2893-2917.
  • 9Mao WM, Zheng WH, Ling ZQ. Epidemiologic risk fac- tors for esophageal cancer development [ J ]. Asian Pac J Cancer Prev, 2011, 12(10): 2461-2466.
  • 10Rice TW, Rusch VW, Ishwaran H, et al. Cancer of the e- sophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Cancer Staging Manuals[J]. Cancer, 2010, 116(16) :3763-3773.

共引文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部